References
- Food and Drug Administration. Enforcement policy for non-invasive remote monitoring devices used to support patient monitoring: guidance for industry and Food and Drug Administration staff [Internet]. Silver Spring (MD): Food and Drug Administration; 2023 [updated 2023 October 19; cited 2024 February 9]. Available from: https://www.fda.gov/media/136290/download.
- Ministry of Food and Drug Safety. Preemptive clinical and approval standards for digital health devices [Internet]. Sejong: Ministry of Food and Drug Safety; 2024 [cited 2024 February 9]. Available from: https://www.mfds.go.kr/usr/rgltnInvtView.do?seq=202300009.
- Kwon S, Choi EK, Lee SR, et al. Comparison of novel telemonitoring system using the single-lead electrocardiogram patch with conventional telemetry system. Korean Circ J 2024;54:140-53.
- Svennberg E, Tjong F, Goette A, et al. How to use digital devices to detect and manage arrhythmias: an EHRA practical guide. Europace 2022;24:979-1005.
- Mittal S, Piccini JP, Snell J, Prillinger JB, Dalal N, Varma N. Improved survival in patients enrolled promptly into remote monitoring following cardiac implantable electronic device implantation. J Interv Card Electrophysiol 2016;46:129-36.
- Spatz ES, Ginsburg GS, Rumsfeld JS, Turakhia MP. Wearable digital health technologies for monitoring in cardiovascular medicine. N Engl J Med 2024;390:346-56.
- Nakayama A, Ishii N, Mantani M, et al. Remote cardiac rehabilitation with wearable devices. Korean Circ J 2023;53:727-43.
- Torous J, Stern AD, Bourgeois FT. Regulatory considerations to keep pace with innovation in digital health products. NPJ Digit Med 2022;5:121.
- Ju JH, Sim B, Lee J, Lee JY. Reimbursement of digital therapeutics: future perspectives in Korea. Korean Circ J 2022;52:265-79.
- Mittermaier M, Venkatesh KP, Kvedar JC. Digital health technology in clinical trials. NPJ Digit Med 2023;6:88.